Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management

• Published in: The journal of clinical endocrinology and metabolism Vol. 102; no. 10; pp. 3621 - 3634
• Main Authors: Paschou, Stavroula Α, Dede, Anastasia D, Anagnostis, Panagiotis G, Vryonidou, Andromachi, Morganstein, Daniel, Goulis, Dimitrios G
• Format: Journal Article
• Language: English
• Published: Washington, DC Endocrine Society 01.10.2017; Copyright Oxford University Press; Oxford University Press
• Subjects: Bone and Bones - drug effects; Bone and Bones - metabolism; Bone turnover; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - complications; Diabetes Mellitus, Type 2 - therapy; Dipeptidyl-peptidase IV; Disease management; Fractures; GLP-1 receptor agonists; Glucagon; Glucagon-like peptide 1; Glucose transporter; Humans; Hypoglycemia; Hypoglycemic Agents - therapeutic use; Insulin; Metformin; Osteoporosis; Osteoporosis - complications; Osteoporosis - therapy; Osteoporotic Fractures - etiology; Osteoporotic Fractures - prevention & control; Peptidase; Practice Guidelines as Topic - standards; Risk Factors; Sodium; Thiazolidinediones

ContextBoth type 2 diabetes (T2D) and osteoporosis are affected by aging and quite often coexist. Furthermore, the fracture risk in patients with T2D is increased. The aim of this article is to review updated information on osteoporosis and fracture risk in patients with T2D, to discuss the effects...